A double‐blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis
- 22 November 1974
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 17 (6) , 923-937
- https://doi.org/10.1002/art.1780170602
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- An approach to the use of immunosuppressive drugs in nonmalignant diseasesJournal of Allergy and Clinical Immunology, 1973
- Cyclophosphamide in Treatment of Systemic Lupus Erythematosus: 7 Years' ExperienceBMJ, 1973
- Efficacy of immunosuppressive drugs in rheumatic diseasesArthritis & Rheumatism, 1973
- THE EFFECT OF AZATHIOPRINE ON LUPUS GLOMERULONEPHRITISMedicine, 1972
- Therapeutic studies in NZB/W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisoloneArthritis & Rheumatism, 1972
- Therapeutic studies in NZB/W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combinationArthritis & Rheumatism, 1972
- CYCLOPHOSPHAMIDETransplantation, 1972
- COMBINED PREDNISOLONE, AZATHIOPRINE, AND CYCLOPHOSPHAMIDE TREATMENT FOR PERSISTENT PROLIFERATIVE GLOMERULONEPHRITIS IN ADULTSThe Lancet, 1971
- Azathioprine in the treatment of systemic lupus erythematosus. A controlled studyArthritis & Rheumatism, 1971
- AZATHIOPRINE AND PREDNISONE IN THE TREATMENT OF ADULTS WITH LUPUS NEPHRITISMedicine, 1970